Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the value of concurrent chemoradiotherapy in
improving the locoregional control and survival of patients with resected locally advanced
HNSCC, a phase III randomized study is proposed. The population studied in this trial is
limited to patients of oral cavity cancer; this could reduce the confounding factor of
varying prognosis in patients of different primary sites of HNSCC.
Phase:
Phase 3
Details
Lead Sponsor:
National Health Research Institutes, Taiwan
Collaborators:
Buddhist Tzu Chi General Hospital Changhua Christian Hospital Chi Mei Medical Hospital China Medical University Hospital Kaohsiung Veterans General Hospital. Koo Foundation Sun Yat-Sen Cancer Center Mackay Memorial Hospital National Taiwan University Hospital Sun Yat-sen University